Sun Pharma agrees to supply at MFN pricing to U.S. medicaid programmes
3 days ago · The Hindu Business
Global
India
& newspaper;
Read Full Article →
Sourced From
The Hindu Business
The U.S. is the company’s largest market for innovative medicines and a cornerstone of its long-term growth strategy, generating approximately 27% of the company’s global revenue.
Source: The Hindu Business — Read full article →
Content sourced from third parties. Copyright belongs to original publishers.
Source: The Hindu Business — Read full article at source →
Content sourced from third parties. Copyright belongs to original publishers. Only excerpt and link are stored under fair use.